Generali Investments Towarzystwo Funduszy Inwestycyjnych Moderna, Inc. Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $157 Billion
- Q1 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Moderna, Inc. stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 400 shares of MRNA stock, worth $13,116. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$13,116
Previous $16.6 Million
31.82%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
864Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$838 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$818 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$583 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$245 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...